Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company
Aurobindo Pharma USA receives FTC approval to acquire Lannett Company in a USD 250 million deal. The transaction is expected to close before the end of June 2026.
US Pharmaceutical Industry | 22/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy